bluebird bio (BLUE)

Bluebird Bio (BLUE) Financial Statements


Bluebird Bio Financial Overview

Bluebird Bio's market cap is currently ―. The company's EPS TTM is $-0.744; its P/E ratio is -1.41; Bluebird Bio is scheduled to report earnings on August 6, 2024, and the estimated EPS forecast is $-0.42. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue$ 12.39M$ 6.89M$ 2.38M$ 858.00K$ 71.00K
Gross Profit$ 1.44M$ 6.89M$ -995.00K$ 40.00K$ 71.00K
EBIT$ -84.73M$ -72.99M$ 21.24M$ 31.97M$ -86.48M
EBITDA$ -83.66M$ -72.02M$ 22.32M$ 33.23M$ -85.09M
Net Income Common Stockholders$ -71.73M$ -72.91M$ 21.24M$ 32.23M$ -76.52M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 174.29M$ 245.30M$ 318.26M$ 180.33M$ 139.63M
Total Assets$ 613.61M$ 663.39M$ 684.02M$ 554.90M$ 520.10M
Total Debt$ 303.71M$ 306.86M$ 273.38M$ 281.39M$ 278.21M
Net Debt$ 129.41M$ 61.55M$ -44.88M$ 101.06M$ 138.58M
Total Liabilities$ 391.07M$ 374.37M$ 338.00M$ 358.56M$ 361.24M
Stockholders Equity$ 222.54M$ 287.19M$ 350.00M$ 196.34M$ 158.86M
Cash Flow-
Free Cash Flow$ -63.88M$ -73.47M$ 5.23M$ 40.57M$ -78.29M
Operating Cash Flow$ -61.85M$ -72.72M$ -86.64M$ -56.32M$ -77.03M
Investing Cash Flow$ 62.08M$ 6.95M$ 82.14M$ 103.24M$ 15.61M
Financing Cash Flow$ 129.88M$ -445.00K$ 130.46M$ -115.00K$ 46.33M
Currency in USD

Bluebird Bio Earnings and Revenue History

Bluebird Bio Debt to Assets

Bluebird Bio Cash Flow

Bluebird Bio Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis